Expand MLYS Menu
MLYS MENU

MLYS Latest Press Releases

-- December 12, 2025 --

Mineralys Therapeutics' Phase 3 Launch-HTN Trial of Lorundrostat Recognized in Inaugural Journal of the American Medical Association (JAMA) "Research of the Year" Roundup Globe Newswire 11:00 AM

-- November 26, 2025 --

Mineralys Therapeutics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- November 10, 2025 --

Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- November 7, 2025 --

Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025 Globe Newswire 6:10 PM

-- November 5, 2025 --

Mineralys Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 4:05 PM

-- November 3, 2025 --

Mineralys Therapeutics to Announce Third Quarter 2025 Financial Results and Host Conference Call on Monday, November 10, 2025 Globe Newswire 8:00 AM

-- October 21, 2025 --

Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025 Globe Newswire 8:00 AM

-- September 30, 2025 --

Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension Globe Newswire 8:00 AM

-- September 5, 2025 --

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need Globe Newswire 9:00 AM

-- September 4, 2025 --

Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:01 PM

-- September 2, 2025 --

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock Globe Newswire 9:33 PM
Mineralys Therapeutics Announces Proposed Public Offering of Common Stock Globe Newswire 4:01 PM

-- August 12, 2025 --

Mineralys Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- August 4, 2025 --

Mineralys Therapeutics to Announce Second Quarter 2025 Financial Results and Host Conference Call on Tuesday, August 12, 2025 Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes